Asthma is the dominant factor for recurrence in chronic rhinosinusitis
The Journal of Allergy and Clinical Immunology: In Practice | Oct 21, 2019
Efficacy and safety of reslizumab in patients with severe asthma with inadequate response to omalizumab: A multicenter, open-label pilot study
The Journal of Allergy and Clinical Immunology: In Practice | Oct 20, 2019
Most read this week